Screening for NAFLD in Flanders
- Conditions
- Non-Alcoholic Fatty Liver Disease
- Interventions
- Other: screening
- Registration Number
- NCT04647409
- Lead Sponsor
- Hasselt University
- Brief Summary
In the Belgian adult population more than half, and numbers are still increasing, of the population is overweight or obese. These people are at risk to develop NAFLD. However, we lack epidemiological data in Belgium. Therefore, it is important to do epidemiological studies to investigate NAFLD prevalence and disease severity based on a non-invasive approach and evaluate how patients are to be referred.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 10000
- 18 years or older,
- able to understand Dutch,
- able to understand the informed consent
- secondary causes of steatosis
- excessive alcohol abuse
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description participants screening -
- Primary Outcome Measures
Name Time Method CLDQ-NAFLD baseline The determination of the prevalence of NAFLD in a general population in Flanders, Belgium by using A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
36-Item Short Form Survey (SF-36) baseline SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hasselt University
🇧🇪Hasselt, Belgium